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Abstract. Gene regulatory networks (GRNs) are crucial in every process of life 
since they govern the majority of the molecular processes. Therefore, the task 
of assembling these networks is highly important. In particular, the so called 
model-free approaches have an advantage modeling the complexities of 
dynamic molecular networks, since most of the gene networks are hard to be 
mapped with accuracy by any other mathematical model. A highly abstract 
model-free approach, called rule-based approach, offers several advantages 
performing data-driven analysis; such as the requirement of the least amount of 
data. They also have an important ability to perform inferences: its simplicity 
allows the inference of large size models with a higher speed of analysis. 
However, regarding these techniques, the reconstruction of the relational 
structure of the network is partial, hence incomplete, for an effective biological 
analysis. This situation motivated us to explore the possibility of hybridizing 
with other approaches, such as biclustering techniques. This led to incorporate a 
biclustering tool that finds new relations between the nodes of the GRN. In this 
work we present a new software, called GeRNeT that integrates the algorithms 
of GRNCOP2 and BiHEA along a set of tools for interactive visualization, 
statistical analysis and ontological enrichment of the resulting GRNs. In this 
regard, results associated with Alzheimer disease datasets are presented that 
show the usefulness of integrating both bioinformatics tools. 
Keywords: Gene Regulatory Network, Biclustering, Microarray, Machine-
Learning. 
1 Introduction 
A gene regulatory network (GRN) is a collection of molecular regulators that 
interact among them and with other substances in the cell to govern the gene 
expression levels of mRNA and proteins (Karlebach and Shamir, 2008; Zamani et al., 
2010). These networks are crucial in every process of life, and several cellular 
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processes are affected by them. The nodes of this network are genes, proteins, their 
corresponding mRNAs, or protein/protein complexes, while the edges indicate a chain 
of dependencies, with cycles corresponding to feedback loops. 
The microarray technology enabled large scale studies that allow the parallel 
measure of gene expression under a given set of conditions. This technology 
introduces a large amount of information to analyze, hence several data analysis 
issues (Alves et al., 2010). There are several techniques that carry out the reverse 
engineering of GRNs from analyzing gene expression data (Alves et al., 2010; De 
Jong, 2002; Espanés et al., 2016; Gallo et al., 2011; Karlebach and Shamir, 2008; 
Lakshmanan et al., 2013; Li et al., 2008; Ponzoni et al., 2007; Pridgeon and Corne, 
2004; Zamani et al., 2010). They vary from Boolean models, model-free approaches 
up to data mining techniques, each of them tries to overcome the disadvantages of the 
previous one. Particularly, one machine-learning approach for the inference of time-
lagged rules, called GRNCOP2 (Gallo et al., 2011), performs this task. These time-
delayed gene regulation rules are a common phenomenon (Bulashevska and Elis, 
2005; Li et al., 2006; Ponzoni et al., 2007; Soinov et al., 2003; van Someren et al., 
2000) and they add complexity and computational cost. The resulting potential 
interactions between genes from the algorithm are used to predict the gene expression 
states of a gene in terms of gene expression values of other genes and to assemble a 
GRN by applying and combining these rules. 
Model-free approaches have an advantage over any mathematical model because 
of the complexities of dynamic molecular networks that are hard to be mapped (Li et 
al., 2006) since this kind of approaches does not need any underlying model. In 
particular, rule-based approaches, a highly abstract model-free technique, offer 
several advantages when data-driven analysis is performed since they require the least 
amount of data, with an important ability to perform inferences, and allow the 
inference of large size models with a higher speed of analysis (Karlebach and Shamir, 
2008). The main disadvantage of this approach is that the reconstruction of the 
relational structure of the network is partial, hence incomplete, for an effective 
biological analysis. This open the doors to the idea of exploring the hybridization of 
these methods with other techniques that enhance the relational structure of the 
network. In this regard, other techniques focus on finding a behavioral pattern for the 
genes on a subset of conditions for the microarray expression data. These techniques 
are called biclustering and aim to infer the biological role of the genes. Particularly 
BiHEA (Gallo et al., 2009) is a Hybrid Biclustering Evolutionary Algorithm that 
performs this task. 
In this work a software suit for the GRNCOP2 algorithm and its integration with 
the BIHEA algorithm is presented. The software also provides several features for 
handling, pre-processing and visualizing microarray data. In the following sections 
the GeRNeT software is presented. First, its features are pronounced along with the 
results of the Alzheimer disease datasets experiments. Then, a comparison with other 
authors work is performed and the biological inferences found by the tool are 
described. 
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2 Material and Methods 
GeRNet is a software suit for the GRNCOP2 algorithm (Gallo et al., 2011) which 
infers time-lagged rules for the reconstruction of GRNs. The tool incorporates the 
BiHEA biclustering algorithm (Gallo et al., 2009) to the GRNCOP2 in order to 
enhance the network with putative relations that GRNCOP2 alone was not able to 
recover from the data. Additionally, the suit provides several features for handling, 
pre-processing and visualizing microarray data. In the following sections, all the 
features of GeRNet are described. The tool is available at: 
http://lidecc.cs.uns.edu.ar/index.php/sw/gernet. 
2.1 Project handling 
GeRNet is based on the concept of project to manipulate microarray data. In this 
regard, the tool provides with a dialog box were the datasets can be added to a new 
project by pressing the "Add datasets..." button. The application allows the selection 
of multiple files, so it is possible to select all the data at once or one by one by 
pressing the button and choosing each file iteratively. The datasets are displayed in 
the dialog box to select if they correspond to Time Series data or Steady State data. It 
is also possible to delete the data from the list individually or by pressing the "Clear 
list" button. 
Additionally, the application requires the specification of the particular CSV 
format of the data, by selecting whether the data has the gene names in the first 
column and/or if it has the sample names in the first row. Also, the data may contain 
gene annotations in the second column of the datasets. If none of these options are 
selected, the application assigns anonymous names in each case. In this regard, all the 
data must be consistent with the selected "Gene and column names" options. As an 
example, if the gene symbol ID in the first column option is selected, then all the 
datasets must meet this convention. This allows the automatic resize and reordering of 
the data rows in the case that they were provided with a different number of genes 
and/or with a different gene ordering. In the case that the data does not have the gene 
names in the first column, they must be provided with the same number of genes and 
in the same order. 
Finally, the software allows to save and to open previously saved projects. The 
saved project contains all the datasets, as well as the gene regulatory network (in case 
that one was inferred) and the parameters for the algorithms. 
2.2 Datasets views and manipulation 
The framework allows different views of the datasets and provides useful tools to 
manipulate them. The datasets viewing window (Fig. 1) shows each data file in a 
different tab and it also indicates whether they correspond to a Time Series or to a 
Steady State data.  If the data contains gene annotations, the corresponding 
information is displayed in a second column. It is also possible to choose between a 
Heat Map view and a Numeric view of the data. In the Heat Map view, the framework 
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allows the selection of the colors representing the above of average and the below of 
average values of the heat map by pressing the "Heat Map Colors" button. 
Whenever the button "Heat Map View" is unselected, the view of the datasets turns 
into the Numeric view mode (Fig. 2).  In this mode, the values of the datasets on each 
sample can be modified by double clicking with the left mouse button into the desired 
cell. Also, it is possible to estimate the missing values of all the datasets by pressing 
the "Estimate Missing Values" button in the secondary option bar. This function 
replaces the cells marked as missed (represented with a 999 value) with an estimation 
of the values obtained by a Bayesian Principal Component Analysis method (BPCA).  
Both views allow for zooming of the datasets with several scales, thus improving 
the visualization. Also, it is possible to transform the data by means of log2, loge, 
log10, z-score, translation (add) and escalation (mult). 
 
Fig. 1.  GeRNeT, Datasets view window, Heat Map View. 
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Fig. 2.  GeRNeT, Datasets view window, Numeric view (Heat Map unselected). 
2.3 The GRNCOP2 algorithm 
In order to run the GRNCOP2 algorithm, it is necessary to have at least one dataset 
loaded in the framework, either by creating a new project or by opening an existing 
one. The algorithm runs by pressing the "Run GRNCOP2"  button in the main 
option bar. As a result, a progress bar appears that shows the movement of the search. 
The results of the search depend on the type of datasets loaded and also on the 
parameters selected for the algorithm. The type of the datasets determines primarily 
the delay of the rules that can be inferred. If all the datasets are Time Series type, then 
the maximum time delay searchable is determined by the dataset with less samples 
minus 4 (this is due to restrictions in the GNRCOP2 algorithm regarding the 
minimum number of samples of the datasets which is 4). If all the datasets are Steady 
State type, then only simultaneous rules can be inferred. In the case when there are 
mixed data types (Time Series and Steady State), the simultaneous rules are inferred 
with all the datasets, whereas the time delay rules are inferred only with the Time 
Delay datasets. 
The default parameters of the GRNCOP2 algorithm are shown in the dialog box of 
Fig. 3. All the parameters of the algorithm are described as follow: 
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Fig. 3.  Parameters of GRNCOP2. 
Accuracy. A real value between 0 and 1 that represents the minimum acceptable 
confidence of the rules that will be reported by the algorithm. All the rules that doesn't 
meet this threshold will be discarded and not reported. 
Percentage. A real value between 0 and 1 that represents the minimum percentage of 
samples that the rules +g1  +g2, -g1  -g2, +g1  -g2 and -g1 
 +g2 need to meet in order to be reported. All the rules that don't meet this 
threshold will be discarded and will not be reported. This allows a fine tuning of the 
search, thus avoiding too many false positives of these kinds of rules since they are 
more likely to be inferred by chance. 
Rule Consensus Accuracy. A real value between 0 and 1 that represents the minimum 
acceptable percentage of datasets that the rules must meet with the Accuracy 
parameter. All the rules that don't meet this threshold will be discarded and will not be 
reported. 
Time Window. An integer value greater or equal to 0 that sets the maximum delay of 
the rules to be inferred. A zero value states that only simultaneous rules will be 
inferred. An x value greater than zero states that the delays of the rules to be inferred 
will be between 0 (simultaneous) and x, including both ends 
Number of Processors. An integer value greater or equal to 1 that sets the maximum 
number of processors that the algorithm can use in order to perform the search. If 
more processors are assigned to the algorithm, then less time will take the search. The 
maximum value is limited to the maximum number of cores available in the host 
machine. 
Number of Rules limit. An integer value greater or equal to 1 that sets the maximum 
number of rules to be displayed by the framework. If the GRNCOP2 algorithm 
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exceeds this limit when it finishes the search, a dialog box will appear asking for two 
options: save the rules in a csv file or continue. If continue is selected, the 
responsiveness of the interface it is not guaranteed since it will depend on the 
hardware over which the software is running.  
Once the search is complete, the GRN View tab will be made available with a 
graph representation of the inferred gene regulatory network along with a list of the 
obtained rules. 
2.4 Gene Regulatory Network view and manipulation 
This section describes the features of this framework to view, modify and 
manipulate the gene regulatory networks inferred by GRNCOP2. Once the 
GRNCOP2 algorithm finishes the search, the gene regulatory network associated with 
the rules inferred is automatically drawn in the "GRN View" tab (Fig. 4). Also, a table 
that contains all the rules appears in the left side of the main window. Each gene in 
the GRN View is represented as a green circle vertex, whereas the rules that relate 
them are directed edges that are drawn accordingly to the following scheme: 
 +/-g1 d==> +/- g2 rules are represented by a directed edge  from g1 to g2 
and state that when g1 is over expressed (under expressed), g2 is activated 
(inhibited) with a delay of d units of time. 
 + g1 d ==> + g2 rules are represented by a directed edge  from g1 to g2 
and state that when g1 is over expressed, g2 is activated with a delay of d units of 
time. 
 - g1 d ==> - g2 rules are represented by a directed edge  from g1 to g2 and 
state that when g1 is under expressed, g2 is inhibited with a delay of d units of 
time. 
 +/- g1 d ==> -/+ g2 rules are represented by a directed edge  from g1 to g2 
and state that when g1 is over expressed (under expressed), g2 is inhibited 
(activated) with a delay of d units of time. 
 + g1 d ==> - g2 rules are represented by a directed edge  from g1 to g2 and 
state that when g1 is over expressed, g2 is inhibited with a delay of d units of time. 
 - g1 d ==> + g2 rules are represented by a directed edge  from g1 to g2 and 
state that when g1 is under expressed, g2 is activated with a delay of d units of 
time. 
Only the genes that are associated by at least one rule are drawn in the gene 
regulatory network. 
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Fig. 4.  Rules inferred by GeRNeT in the GRN View tab. 
 
Fig. 5.  A different view of the GRN View tab. 
The GRN View offers several views of the network (Fig. 5). It contains one tab 
called "All delays" that shows the entire network with all the time delays, and also 
contains one tab per time delay inferred that shows only the rules of that specific time 
delay. Below the network graph view (Fig. 4) there is the Reference panel that 
contains the indication of the meaning of each edge in the graph. It also allows to hide 
any type of interaction by clicking on the button that contains the edge. Above the 
network graph view, there is an option bar aimed at customizing the current view of 
the network. It allows the selection of several layouts that automatically rearrange the 
genes according to some specific criteria. Also, it is possible to add or hide several 
types of labels for the edges and vertexes of the graph, like the confidence ("Show 
Accuracy / BiHEA Score" button) and time delay ("Show Time Delay" button) of the 
rules, and the names of the genes ("Show Gene Names" button). It also allows to hide 
genes accordingly to a specific selection in the graph or by a previously created gene 
list file. The "Filter by Selected Genes" button hides all the genes except the ones that 
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are selected in the graph, whereas the "Filter by Gene List File" button hides all the 
genes except the ones that are in the gene list of the selected file. The format of this 
file is a text archive with each gene name separated by a new line. 
On the left side of the GRN View there is the tool bar used to interact with the 
network. It contains three tools: the arrow  tool, the hand  tool and the pen  
tool. 
Arrow  tool. This tool turns the view in picking mode: 
 Left mouse button press on a gene or association to select it. 
 Left mouse button + shift press on a gene or association to add or toggle selection. 
 Left mouse button + drag on a gene to move all selected genes. 
 Left mouse button + drag to select genes in a rectangle. 
 Left mouse button + shift + drag to add to selection with ge es in a rectangle. 
Hand  tool. This tool turns the view in the transforming mode: 
 Left mouse button + drag to translate the view. 
 Left mouse button + shift + drag to rotate the view. 
 Left mouse button + ctrl (or command) + drag to shear the view. 
Pen  tool. This tool turns the view in the editing mode: 
 Left mouse button press on empty space creates a new gene. 
 Left mouse button on a gene, followed by a drag to another gene creates a directed 
edge between them. 
With any tool.  
 A right mouse button click on an empty space with no gene selection shows a 
popup menu (Fig. 6) to create a new gene, and allows to export the current view 
(see the Exporting the Results section). If at least one gene is picked, then the 
popup menu shows options for creating a new gene, deleting the selected genes, 
finding new associations that involve the selected genes through BiHEA (see the 
Integration with BiHEA section) and exporting the current view. 
 A right mouse button click on a gene shows a popup with several actions. If no 
genes are picked, then the only option that is shown is for exporting the current 
view. Otherwise, you can create new associations between the selected genes and 
the clicked gene as a target, delete the selected genes, find new associations that 
involve the selected genes through BiHEA, and export the current view. 
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 The mouse wheel allows to scale the view. When the scale is equal or less than 
one, the view is scaled. When the scale is more than one, the layout is scaled. 
 Hover a gene with the mouse and the corresponding gene annotation (if any) will 
pop up on screen. 
 
Fig. 6.  Right click popup menu on the GRN View tab. 
2.5 Integration with BiHEA 
The framework incorporates the BiHEA algorithm to allow the inference of new 
interactions that were not recovered by the GRNCOP2 algorithm. The BiHEA is an 
evolutionary biclustering algorithm aimed at finding co-expression (similar or 
opposed) between genes that may only occur in a subset of the samples. In this regard, 
since BiHEA only find subsets of genes that are related in a subset of samples, there is 
the need of additional mechanisms to allow the recovery of interactions that can be 
compared with the rules inferred by GRNCOP2, and then, added to the gene 
regulatory network.  
The integration of the BiHEA algorithm involves several steps. First, the user must 
select in the GRN View tab what genes are of interest in order to find new 
interactions. These genes will act as potential regulators for the other genes in the 
datasets. Then, by clicking with the right mouse button on the view, a popup menu 
will be displayed showing the option "Find new associations with BiHEA" (ref. Fig. 
6). The search begins once that option is clicked, the results are displayed in Fig. 8. 
The search is related to the current time delay displayed in the network, i.e., if the 
time delay 1 is displayed, then the algorithm will search for rules with a delay of one-
time unit. If all the delays are shown (i.e., the tab "All rules" is selected) then a dialog 
will show up to allow the user to select one specific time delay. This time delay 
affects the way that the data is considered by the algorithm, since all the genes that 
will act as potential regulators will be displaced in the selected time delay in the 
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datasets with respect to the other genes. As an example, suppose a dataset D1 with 
five genes and ten samples (Fig. 7). If the genes that are selected are g2 and g4, and 
the time delay is 1, then the actual matrix in which the search will be performed is the 
D1'. 
 
Fig. 7. Example for the matrix D1’ in which the algorithm will perform the search if D1 is the 
original dataset, the genes selected are g2 and g4 and the time delay is 1. 
The next step performs a search of biclusters with the BiHEA algorithm in all the 
datasets separately. Once all the searches finish, a pairwise analysis is performed for 
each one of the selected genes. To make the explanation simpler, let us use the 
previous example (Fig. 7). If g2 and g4 are selected, then the pairwise analysis 
computes for each pair of genes g2-g1, g2-g3, g2-g4, g2-g5 and g4-g1, g4-g2, g4-g3, 
g4-g5, the number of biclusters of D1' for which both genes of the pair are members. 
Then those values are averaged with the values of the other datasets in order to obtain 
the final BiHEA Score for each interaction. 
Finally, when all this process is done, a dialog box is shown (Fig. 8) with the 
highest BiHEA Scores along with the corresponding pair of genes of the interaction, 
allowing the user to select the desired associations and discarding the rest. The 
selected interactions will be added automatically to the gene regulatory network only 
if they were not present before. 
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Fig. 8. Dialog box with the highest BiHEA Scores and the corresponding pair of genes in the 
interaction. The user can select the desired rules and discard the others. 
If the search was performed for a time delay 0, i.e. for simultaneous rules, then 
each pair of genes is displayed twice, one for each gene acting as a regulator. This is 
because a priori it cannot be assumed any causality in the relation since the only 
information that is known is the co-expression of both genes. On the other hand, if the 
search was performed with a delay greater than 0, i.e., for time delayed rules, then it 
can be assumed that the expression (or inhibition) of the target gene is due to the 
expression (or inhibition) of the regulator gene in the previous samples. The opposite 
regulation is also inferred since the BiHEA algorithm builds the biclusters considering 
both the similar and the opposed expression profiles of each gene. In order to 
differentiate the BiHEA Score of the Accuracy of GRNCOP2, given that both values 
have different interpretations, the BiHEA Score number is visualized in the network 
with the letters BS at the end of the value. 
Finally, there are several parameters for the BiHEA algorithm that can be tuned 
(Fig. 9), as described below: 
 
Fig. 9. BiHEA parameters. 
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Population size. An integer value greater than 1 that represents the size of the main 
population maintained by the evolutionary algorithm. This is the number of biclusters 
that BiHEA will return.  
Max Generations. An integer value greater than 1 that refers to the number of 
iterations that the algorithm will perform improving the solutions until it stops. 
Greater values yield to solutions that are more optimized, but this also entails more 
execution time. 
Mutation Probability. A real value between 0 and 1 that sets the probability of the 
mutation operator in the evolutionary process. 
Alpha. A real value that sets a threshold for the local search in the evolutionary 
algorithm. A greater value improves the execution time but also deteriorates the 
quality of the solutions; and vice versa. 
Seed. An integer value that sets the seed for the random number generator of the 
evolutionary algorithm. 
Max Number of Rows. An integer positive value that sets the size of the table in the 
dialog box that shows the rules found by BiHEA. 
2.6 Exporting the results 
There are two kinds of results that can be exported from the framework: the rules 
inferred by the algorithms and the graphical view of the network. In order to export 
the rules, the software suit opens a dialog box to save the file in a coma separated 
value format. On the other hand, in order to export the graphical view of the network, 
the framework shows a dialog box with several options (Fig. 10). There are several 
formats available, such as PDF, EPS, JPG, PNG and many other along with options to 
tune it. 
 
Fig. 10. Several options to export the graphical view of the network. 
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3 Results and Discussion 
In order to test the tool’s performance, a microarray dataset obtained from GEO 
(Gene Expression Omnibus: http://www.ncbi.nlm.nih.gov/geo/) was used. The 
dataset, called GSE1297 (Blalock et al., 2004), analyzes hippocampal gene expression 
of nine control and 22 AD subjects of varying severity; it shows the progression of the 
Alzheimer Disease (AD) in terms of patients with no disease present, called control 
samples, patients with the disease on their first stages, called incipient samples, 
patients with moderate symptoms of the disease, called moderate samples, and 
patients on their final stages, called severe samples. 
The GeRNet Tool was used on each matrix from the dataset GSE1297 (control, 
incipient, moderate and severe) to obtain a list of rules from the gene regulatory 
network obtained. This list of rules was calculated for each matrix from the dataset, 
from now on called list R. Notice that there is an R list for each of the four matrix of 
the dataset, each of them indicates the progression of the disease. The next step was to 
run the BiHEA integration, as stated in section 2.5, in order to obtain a new set of 
extra rules, called list B for each matrix. This list contains the rules or interactions not 
detected by the algorithm of GRNCOP2 by using the Hybrid MOEA explained in the 
previous section. 
In order to compare the rules found by GeRNeT with the ones reported in Kong et 
al. (Kong et al., 2014), the first ones were reduced using the same Gene Regulators 
and Gene Targets as those reported by Kong et al. The results show that with the 
inclusion of BiHEA, several new rules were found. Kong et al. method uses an 
independent component analysis (ICA) instead of clustering methods, in order to 
select the differentially expressed genes on the same dataset that was introduced 
previously. The results show an increase of rules found by GeRNeT, only after the 
application of the BiHEA integration, some of them are found by Kong et al. and 
several others are not presented in their work.  These rules are explained in the 
following section. 
Figures 13 to 16 contrast the association rules obtained by GeRNeT and Kong et 
al. for each AD dataset. The interactions highlighted in blue corresponds to the rules 
found by Kong et al. that are also inferred by GRNCOP2, without using BiHEA tools. 
The interactions highlighted in orange represent those found by Kong et al. that are 
also inferred by hybridizing GRNCOP2 with BiHEA. In other words, the orange rules 
cannot be detected using GRNCOP2 alone. Highlighted in purple are those rules 
found by hybridizing GRNCOP2 with BiHEA, but are not reported by Kong et al. 
Finally, the rules in grey are found for GRNCOP2 alone, but are not detected by Kong 
et al. Regarding the nodes, the ones that are filled in blue are the Regulator genes, and 
the ones that are empty are the Target ones. We focus our discussion on the purple 
highlighted rules, which are those that are not found in the paper of Kong et al. while 
are found by the GERNET tool using the BiHEA integration. This set of rules are 
explained on the following section in detail and additional bibliography supporting 
them is cited.  
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Fig. 11. All the rules or interactions found by GeRNeT using GSE1297 control dataset. 
Highlighted in blue are the rules found also by Kong et al., highlighted in orange are the rules 
found both by Kong et al. and by the GeRNeT tool using the BiHEA integration, and finally the 
rules that are not present in Kong’s work while are found by GeRNeT using the BiHEA 
integration are highlighted in purple. The nodes filled in blue are the Regulator Genes. 
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Fig. 12. All the rules or interactions found by GeRNeT using GSE1297 incipient dataset. The 
highlighted colors are as stated in Fig. 11 
 
Fig. 13. All the rules or interactions found by GeRNeT using GSE1297 moderate dataset. The 
highlighted colors are as stated in Fig. 11. 
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Fig. 14. All the rules or interactions found by GeRNeT using GSE1297 severe dataset. The 
highlighted colors are as stated in Fig. 11. 
3.1 Biological relevance of the results 
As stated before, the rules found by GeRNeT were highlighted in different colors 
according to the source of its finding (see figures 13 to 16). In blue are the rules 
reported by Kong (Kong et al., 2014) and found by the GRNCOP2 without the 
integration of the biclustering technique. In orange are the rules also found by Kong 
and GRNCOP2 hybridized with BiHEA. The biological relevance of these sets of 
rules, blue and orange, are explained in Kong’s work and, therefore, we decide do not 
focus on them. Nevertheless, it is important to mention that combination of 
GRNCOP2 with the biclustering technique detects several rules that were unable to be 
reported for GRNCOP2 alone. 
The other highlighted rules, the purple ones, are those that were found by using the 
hybridized method integrating BiHEA, and they were not reported by Kong’s work. 
These rules are explained in more detail in Tables 1 and 2. In the first table, a brief 
explanation of each gene involved is presented. In the second table, information 
related to the biological relevance of each purple rule is presented. Notably, most of 
these relations are associated with the GO term quinolinate catabolic process that is 
strongly associated with the Alzheimer disease (AD) in the bibliography. The 
chemical reactions and pathways contained in the quinolinate catabolic process result 
in the breakdown of quinolinate, the anion of quinolinic acid. The quinolinate 
synthase is an enzyme that catalyzes glycerone phosphate and iminosuccinate and 
affords quinolinic acid (Ashihara et al., 2011). Studies have found in the post-mortem 
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brains of AD patients higher neuronal quinolinic acid levels and that quinolinic acid 
can associate with tau protein (Schwarcz et al., 2012; Severino et al., 2011). 
Furthermore, it has been demonstrated that quinolinic acid increases tau 
phosphorylation in vitro in human fetal neurons and induces ten neuronal genes, 
including some known to correlate with AD. In immunoreactivity studies, it has been 
found that quinolinic acid immunoreactivity is strongest in glial cells that are located 
close to amyloid plaques and that there is immunoreactivity with neurofibrillary 
tangles. 
Table 1. In the following table a list of the genes involved in the GRN is shown in the column 
Gene. In the column Type the gene role is explained, if it is Target, Regulator or both. Finally 
in the Function column the gene function is briefly explained. 
Type Gene Function 
Ta
rg
et
 &
  
R
eg
ul
at
or
 
ge
ne
s 
ANAPC5 This is a protein-coding gene. Anaphase Promoting Complex Subunit 5 
protein, is involved in the pathway protein ubiquitination, which is part of 
protein modification. It is a cell cycle-regulated E3 ubiquitin ligase that 
regulates progression through mitosis and the G1 phase of the cell cycle, as 
member of the anaphase promoting complex/cyclosome (APC/C).  
CSNK1A1 Casein Kinase 1 Alpha 1 is a protein-coding gene. Casein kinases are 
operationally defined by their preferential utilization of acidic. It can 
phosphorylate several proteins. Contributes in Wnt signaling. Might be 
relevant in segregating chromosomes during mitosis, and in keratin 
cytoskeleton disassembly and in that way, it can regulate epithelial cell 
migration 
DICER1 This gene encodes a protein possessing an RNA helicase motif 
containing a DEXH box in its amino terminus and an RNA motif in the 
carboxyl terminus. The encoded protein functions as a ribonuclease and is 
necessary by the RNA interference and small temporal RNA (stRNA) 
pathways to generate the active small RNA component that inhibits gene 
expression. Alternative splicing results in multiple transcript variants. 
DPP6 This gene encodes a single-pass type II membrane protein, which 
belongs to the peptidase S9B family of serine proteases. This protein does 
bind particular voltage-gated potassium channels and modifies their 
expression and biophysical properties. 
FKBP1A The protein encoded by this gene belongs to the immunophilin protein 
family, which is relevant in immunoregulation and basic cellular processes 
comprising protein folding and trafficking. 
Ta
rg
et
 g
en
es
 
KPNA2 In the energy-dependent translocation through the nuclear pore 
complex, in the process of import of proteins into the nucleus, is required a 
nuclear localization sequence (NLS). The protein encoded by KPNA2 gene 
interacts with the NLSs of DNA helicase Q1 and SV40 T antigen and may 
be involved in the nuclear transport of proteins. 
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NCOA1 This gene encodes a protein that is a transcriptional coactivator for 
nuclear hormone and steroid receptors. The Nuclear Receptor Coactivator 
1 protein binds nuclear receptors directly and stimulates the transcriptional 
activities in a hormone-dependent fashion. 
NFIB The Nuclear factor 1 B-type protein-coding by NFIB gene, recognizes 
and binds a palindromic sequence existing in cellular and viral promoters 
and in the begining of replication of adenovirus type 2. These proteins are 
individually capable of activating transcription and replication. 
PDE4C The protein encoded by this gene hydrolyzes the second messenger 
cAMP, which is a regulator and mediator of a number of cellular responses 
to extracellular signals. Thus, this protein plays a key role in many 
important physiological processes. 
PICALM This gene encodes a Phosphatidylinositol-binding clathrin assembly 
protein that collects clathrin and adaptor protein complex 2 (AP2) to cell 
membranes at sites of coated pit formation and clathrin vesicle assembly. 
The polymorphisms of this gene are associated with the risk of Alzheimer 
disease. 
PSMA1 The proteasome is a multi-catalytic proteinase complex, whose main 
role is to cleave peptides with Arg, Phe, Tyr, Leu, and Glu. The 
proteasome cleaves peptides in an ATP/ubiquitin-dependent process in a 
non-lysosomal pathway. This gene encodes a represent of the peptidase 
T1A family, which is a 20S core alpha subunit. 
SFPQ RNA and DNA binding protein, which participates in many nuclear 
processes. Essential pre-mRNA splicing factor necessary in spliceosome 
formation, at early stages, and for splicing catalytic step II, probably as a 
heteromer with NONO. The SFPQ-NONO heteromer associated with 
MATR3 may play a role in nuclear retention of defective RNAs, and may 
be involved in DNA unwinding by modulating the function of 
topoisomerase I/TOP1 
SLC35E1 The solute carrier family 35 member E1 protein coding by this gene has 
a putative transporter function. 
SMARCA4 The transcription activator BRG1 protein-coding by this gene is a 
transcriptional coactivator collaborating with nuclear hormone receptors to 
increase transcriptional activation. In resting neurons, transcription of the 
c-FOS promoter is inhibited by BRG1-dependent recruitment of a 
phospho-RB1-HDAC repressor complex. 
TFAM This gene encodes a relevant mitochondrial transcription factor 
comprising two high mobility group motifs. The encoded protein also 
functions in mitochondrial DNA replication and repair.  
 
TUBB This gene encodes a beta tubulin protein. This protein and alpha tubulin 
conforms a dimer, working as a structural component of microtubules. 
Mutations in this gene are responsible for cortical dysplasia, complex, 
together with several brain malformations. 
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BUB3 This gene encodes a mitotic checkpoint protein involved in spindle-
assembly checkpoint function and a function in promoting the 
establishment of correct kinetochore-microtubule (K-MT) attachments. 
The BUB1/BUB3 complex plays a role in the inhibition of anaphase-
promoting complex or cyclosome (APC/C) when a spindle-assembly 
checkpoint is activated. 
COPA Protein transport from the endoplasmic reticulum to Golgi 
compartments is facilitated in part by non-clathrin-coated vesicular coat 
proteins (COPs). Seven coat proteins have been identified, and they 
represent subunits of a complex known as coatomer, encoded by COPA 
gene. 
E2F4 The protein encoded by this gene is a member of the E2F family of 
transcription factors. The E2F family has a central role in the regulation of 
cell cycle and action of tumor suppressor proteins. Besides, it is a target for 
small DNA tumor viruses. 
POLR2E The POLR2E gene encodes the fifth largest subunit of RNA 
polymerase II, the polymerase responsible for the synthesis of messenger 
RNA (mRNA) in eukaryotes.  
PTBP1 The PTBP1 gene belongs to the subfamily of ubiquitously expressed 
heterogeneous nuclear ribonucleoproteins (hnRNPs). The hnRNPs are 
RNA-binding proteins and they complicate with heterogeneous nuclear 
RNA (hnRNA). These proteins are linked with pre-mRNAs in the nucleus 
and occur to influence pre-mRNA processing and other features of mRNA 
metabolism and transport. 
RNF38 The protein coding by RNF38 gene plays as an E3 ubiquitin-protein 
ligase capable to ubiquitinate p53/TP53 that promotes its relocalization to 
discrete foci associated with PML nuclear bodies. The RING motif is a 
zinc-binding domain found in a large set of proteins, which is relevant in 
several cellular processes such as development, signal transduction, 
oncogenesis, and apoptosis. Multiple transcript variants encoding different 
isoforms have been found for this gene.  
STIP1 The protein encoded by this gene is an adaptor protein that coordinates 
some functions in protein folding. It is also involved in pre-mRNA 
splicing, specifically in spliceosome disassembly during late-stage splicing 
events. 
R
eg
ul
at
or
 g
en
es
 
ZNF207 ZNF207/BuGZ is principally integrated of disordered low-complexity 
regions and undergoes phase transition or coacervation to define 
temperature-dependent liquid droplets. Coacervation activates microtubule 
bundling and concentrates tubulin, activating microtubule polymerization 
and assembly of spindle by increasing the concentration of its building 
blocks. Besides, acts as a regulator of mitotic chromosome alignment by 
mediating the kinetochore loading and stability of BUB3. 
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Table 2. In the following table each purple rule (see figures 13 to 16) is explained using the 
Enrichment Rule taken from GO. 
Regulator Target Enrichment Rule 
ANAPC5 NFIB Regulation of ubiquitin-protein ligase activity 
involved in mitotic cell cycle 
ANAPC5 SFPQ Quinolinate catabolic process 
ANAPC5 SLC35E1 Regulation of ubiquitin-protein ligase activity 
involved in mitotic cell cycle 
ANAPC5 TFAM Quinolinate catabolic process 
BUB3 DICER1 Quinolinate catabolic process 
BUB3 FKBP1A Quinolinate catabolic process 
BUB3 KPNA2 Quinolinate catabolic process 
BUB3 PSMA1 Quinolinate catabolic process 
COPA DICER1 Quinolinate catabolic process 
COPA KPNA2 Quinolinate catabolic process 
COPA PDE4C Quinolinate catabolic process 
E2F4 ANAPC5 Quinolinate catabolic process 
E2F4 DICER1 Quinolinate catabolic process 
E2F4 NFIB Quinolinate catabolic process 
E2F4 SMARCA4 Quinolinate catabolic process 
POLR2E ANAPC5 Quinolinate catabolic process 
POLR2E DICER1 Quinolinate catabolic process 
POLR2E PSMA1 Quinolinate catabolic process 
PTBP1 CSNK1A1 Quinolinate catabolic process 
PTBP1 NCOA1 Quinolinate catabolic process 
PTBP1 NFIB Quinolinate catabolic process 
PTBP1 SLC35E1 Quinolinate catabolic process 
RNF38 DICER1 Quinolinate catabolic process 
RNF38 KPNA2 Quinolinate catabolic process 
RNF38 SMARCA4 Quinolinate catabolic process 
STIP1 CSNK1A1 Quinolinate catabolic process 
STIP1 NCOA1 Quinolinate catabolic process 
STIP1 PICALM Quinolinate catabolic process 
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STIP1 TFAM Quinolinate catabolic process 
STIP1 TUBB Quinolinate catabolic process 
ZNF207 CSNK1A1 Quinolinate catabolic process 
ZNF207 DPP6 Quinolinate catabolic process 
ZNF207 NCOA1 Protein stabilization 
ZNF207 NFIB Protein stabilization 
 
4 Conclusions 
In this work the importance and complexity of the inverse engineering of GRNs 
was assessed, along with the benefits and advantages of using model-free methods 
above the mathematical ones. The main disadvantage of model-free approaches was 
also addressed along with the importance of hybridizing these rule-based methods 
with other strategies that improve the inference of biological meaningful regulatory 
networks. This led to the presentation of a new software tool GeRNeT that 
incorporated this hybridization between the algorithm GRNCOP2 (Gallo et al., 2011) 
and the biclustering technique BiHEA (Gallo et al., 2009), together with several 
analysis facilities. 
In order to evaluate the integration with BiHEA, a case study analysis was 
performed, using an AD progression dataset (Blalock et al., 2004). The analysis 
involved a contrast between the results obtained with the algorithm GRNCOP2 and 
the results added by the integration of BiHEA using the GeRNeT tool. These results 
were compared with the ones reported by Kong et al. (Kong et al., 2014) using the 
same datasets. From these studies, it was possible to conclude that the knowledge 
extracted by BiHEA provides relevant associations that cannot be detected by 
GRNCOP2 nor by Kong et al. In this way, it is evident that the collaboration between 
two model-free strategies of different characteristics allows to reach GRNs with more 
information. In the future, we hope to deepen in the evaluation and improvement of 
this tool with other analysis scenarios and also consider novel additional hybridization 
strategies. 
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